Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats.
暂无分享,去创建一个
S. Martínez-Revelles | M. Salaices | M. Alonso | R. Hernanz | Angela Martín | M. T. Barrús | A. Aguado | R. Palacios | J. V. Pérez-Girón
[1] Q. Su,et al. Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction , 2014, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[2] M. Barančík,et al. Effects of PPARγ Agonist Pioglitazone on Redox-Sensitive Cellular Signaling in Young Spontaneously Hypertensive Rats , 2013, PPAR research.
[3] R. Nagai,et al. Pioglitazone ameliorates systolic and diastolic cardiac dysfunction in rat model of angiotensin II-induced hypertension. , 2013, International journal of cardiology.
[4] J. Redondo,et al. Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. , 2013, Antioxidants & redox signaling.
[5] M. Yanagisawa,et al. ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy. , 2012, Life sciences.
[6] A. Briones,et al. Pioglitazone treatment increases COX‐2‐derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function , 2012, British journal of pharmacology.
[7] Y.-Y. Du,et al. Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[8] E. Schiffrin,et al. Endothelin in hypertension: an update , 2012, Current opinion in nephrology and hypertension.
[9] A. Briones,et al. Peroxisome proliferator-activated receptor-&ggr; activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress , 2012, Journal of hypertension.
[10] J. Tamargo,et al. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. , 2012, Free radical biology & medicine.
[11] J. Pollock,et al. ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells. , 2011, Journal of the American Society of Nephrology : JASN.
[12] David Lagares,et al. Role of endothelin in the cardiovascular system. , 2011, Pharmacological research.
[13] L. Stow,et al. Endothelin‐1 gene regulation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] Steven J Brown,et al. A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells. , 2010, ACS chemical biology.
[15] M. Simionescu,et al. Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. , 2010, Biochemical and biophysical research communications.
[16] J. Chan,et al. Oral Intake of Rosiglitazone Promotes a Central Antihypertensive Effect Via Upregulation of Peroxisome Proliferator-Activated Receptor-&ggr; and Alleviation of Oxidative Stress in Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats , 2010, Hypertension.
[17] A. Knox,et al. Endothelin-1 (ET-1) Increases the Expression of Remodeling Genes in Vascular Smooth Muscle through Linked Calcium and cAMP Pathways , 2010, The Journal of Biological Chemistry.
[18] Chuanqin Fang,et al. Impaired Peroxisome Proliferator-activated Receptor-γ Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension* , 2010, The Journal of Biological Chemistry.
[19] Yen-Ling Chen,et al. Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts. , 2010, International journal of cardiology.
[20] B. Yin,et al. Downregulating osteopontin reduces angiotensin II-induced inflammatory activation in vascular smooth muscle cells , 2009, Inflammation Research.
[21] A. Briones,et al. p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats , 2009, Journal of hypertension.
[22] D. Harrison,et al. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. , 2008, Free radical biology & medicine.
[23] C. Yabe-Nishimura,et al. The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathway. , 2008, Biochemical and biophysical research communications.
[24] M. Yanagisawa,et al. Endothelin: 20 years from discovery to therapy. , 2008, Canadian journal of physiology and pharmacology.
[25] M. Simionescu,et al. AP-1–Dependent Transcriptional Regulation of NADPH Oxidase in Human Aortic Smooth Muscle Cells: Role of p22phox Subunit , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[26] K. Kamata,et al. Relationships among ET-1, PPARγ, oxidative stress and endothelial dysfunction in diabetic animals(Hirosi Kuriyama Award 2007 Memorial Review) , 2008 .
[27] K. Kamata,et al. Relationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animals. , 2008, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.
[28] A. Briones,et al. Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats , 2008, British journal of pharmacology.
[29] D. Pearse,et al. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. , 2008, American journal of physiology. Renal physiology.
[30] Ling-Yun Wu,et al. PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR‐γ AGONISTS ATTENUATE ANGIOTENSIN II‐INDUCED COLLAGEN TYPE I EXPRESSION IN ADVENTITIAL FIBROBLASTS , 2008, Clinical and experimental pharmacology & physiology.
[31] C. Glass,et al. PPARs and molecular mechanisms of transrepression. , 2007, Biochimica et biophysica acta.
[32] A. Briones,et al. Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.
[33] K. Kamata,et al. Mechanisms underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats. , 2007, Free radical biology & medicine.
[34] E. Schiffrin,et al. Inhibitory effects of PPAR-gamma on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats. , 2007, Journal of the American Society of Hypertension : JASH.
[35] M. Quon,et al. Treatment of Spontaneously Hypertensive Rats With Rosiglitazone and/or Enalapril Restores Balance Between Vasodilator and Vasoconstrictor Actions of Insulin With Simultaneous Improvement in Hypertension and Insulin Resistance , 2006, Diabetes.
[36] E. Schiffrin,et al. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. , 2006, Vascular pharmacology.
[37] Marta Ruiz-Ortega,et al. Renal and vascular hypertension-induced inflammation: role of angiotensin II , 2006, Current opinion in nephrology and hypertension.
[38] C. Thiemermann,et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. , 2006, European journal of pharmacology.
[39] M. Sánchez-Hidalgo,et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. , 2005, Biochemical pharmacology.
[40] A. Briones,et al. Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses , 2005, Journal of hypertension.
[41] R. Wu,et al. Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats. , 2005, Free radical biology & medicine.
[42] Y. Surh,et al. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. , 2004, Biochemical pharmacology.
[43] N. Chang,et al. Role of Reactive Oxygen Species-Sensitive Extracellular Signal-Regulated Kinase Pathway in Angiotensin II-Induced Endothelin-1 Gene Expression in Vascular Endothelial Cells , 2004, Journal of Vascular Research.
[44] Jaung-Geng Lin,et al. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. , 2004, Cardiovascular research.
[45] T. Cheng,et al. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. , 2003, Journal of the American College of Cardiology.
[46] E. Araki,et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. , 2003, Diabetes.
[47] L. Musiari,et al. Endothelin-A Receptors Mediate Renal Hemodynamic Effects of Exogenous Angiotensin II in Humans , 2003, Hypertension.
[48] I. Yamaguchi,et al. Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats. , 2002, Clinical science.
[49] E. Schiffrin,et al. Structure, Endothelial Function, Cell Growth, and Inflammation in Blood Vessels of Angiotensin II–Infused Rats: Role of Peroxisome Proliferator–Activated Receptor-&ggr; , 2002, Circulation.
[50] S. Boyault,et al. PPAR-γ ligands modulate effects of LPS in stimulated rat synovial fibroblasts , 2002 .
[51] J. Egido,et al. Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[52] K. Subbaramaiah,et al. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. , 2001, The Journal of biological chemistry.
[53] P. Fasching,et al. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. , 2000, Diabetes.
[54] A. Pessina,et al. Interactions between endothelin-1 and the renin–angiotensin–aldosterone system , 1999 .
[55] S. Rajagopalan,et al. Role for endothelin-1 in angiotensin II-mediated hypertension. , 1997, Hypertension.
[56] Y. Xia,et al. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. , 1995, The Journal of clinical investigation.
[57] H. Kawasaki,et al. Inhibition of plasma endothelin-1 concentration by captopril in patients with essential hypertension. , 1994, Clinical nephrology.
[58] 今井 泰平. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells , 1993 .
[59] T. Resink,et al. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. , 1990, Cell regulation.
[60] D. Hwang,et al. Involvement of Reactive Oxygen Intermediates in Cyclooxygenase-2 Expression Induced by Interleukin-1 , Tumor Necrosis Factor-a , and Lipopolysaccharide , 2022 .